About Zhejiang Jiuzhou Pharmaceutical Company

The company, founded in 1998 and headquartered in Taizhou, Zhejiang, is a leading innovative drug CDMO enterprise. It provides global pharmaceutical companies with one-stop drug R&D, production solutions and professional services from pre-clinical CMC, clinical phase I, II, and III, NDA to commercial listing, and has set a successful example of transformation of traditional domestic generic API companies into innovative drug CDMO companies. The company is a leading, technology-driven CDMO enterprise dedicated to providing one-stop pharmaceutical customized R&D and production (CDMO) services for global pharmaceutical companies, biotechnology companies, scientific research institutions, etc., including small molecule chemical drugs, peptide drugs, conjugated drugs, and small nucleic acid drugs. The main product categories include custom drug development and manufacturing business (CDMO), specialty APIs and intermediates business. Corporate honors: It has successively won honors such as the top 100 enterprises in the national pharmaceutical industry, leading national API export enterprises, national high-tech enterprises, national technological innovation demonstration enterprises, the top 100 pharmaceutical industry enterprises in China, the “three” cultivation pilot enterprises in Zhejiang Province, and the “Jiuzhou” brand has won the “Zhejiang Export Famous Brand” and a national service-oriented manufacturing demonstration enterprise. The company has received many honors, including the top 100 enterprises in China's pharmaceutical industry, the most growing enterprise in the Chinese pharmaceutical industry, the top 20 most competitive listed Chinese pharmaceutical companies, and the 9th Zhejiang Provincial People's Government Quality Management Innovation Award. The company won honors such as “2023 Top 20 Chinese Pharmaceutical CDMO Companies”.